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Background. Hypoplastic left heart syndrome (HLHS) is an etiologically 
multifactorial congenital heart disease affecting one in 5,000 newborns. 
Thirty years ago there were no treatment options for this pathology and 
the  natural course of the  disease led to death, usually within the  first 
weeks of life. Recently surgical palliative techniques have been developed 
allowing for a five-year survival in more than half the cases.
Materials and methods. We reviewed literature available on HLHS, 
specifically its anatomy, embryology and pathophysiology, and treatment. 
The  Pubmed and ClinicalKey databases were searched using the  key 
words hypoplastic left heart syndrome, foetal aortic valvuloplasty, foetal 
septoplasty, Norwood procedure, bidirectional Glenn procedure, Fontan 
procedure, hybrid procedure. The relevant literature was reviewed and in-
cluded in the article. We reported a case from Children’s Clinical Univer-
sity Hospital, Riga, to illustrate treatment tactics in Latvia.
Results. There are three possible directions for therapy in newborns 
with HLHS: orthotopic heart transplantation, staged surgical palliation 
and palliative non-surgical treatment or comfort care. Another treatment 
mode – foetal therapy – has arisen. Staged palliation and full Fontan cir-
culation is a temporary solution, however, the only means for survival un-
til heart transplantation. Fifty to 70% of patients who have gone through 
all three stages of palliation live to the age of five years.
Conclusions. The  superior mode of treatment is not yet clear and 
the management must be based on each individual case, the experience of 
each clinic, as well as the financial aspects and will of the patient’s parents.
Keywords: hypoplastic left heart syndrome, Norwood procedure, bidi-
rectional Glenn procedure, Fontan procedure, hybrid procedure, balloon 
valvuloplasty
Introduction
Hypoplastic left heart syndrome (HLHS) is an eti-
ologically multifactorial congenital heart disease 
affecting one in 5,000 newborns. Thirty years ago 
there were no treatment options for this pathology 
and the natural course of the disease led to death, 
usually within the first weeks of life. Recently sur-
gical palliative techniques have been developed 
allowing for a five-year survival in more than half 
the cases.
This article reviews the pathophysiology, treat-
ment options and outcomes of the disease, as well 
as the current situation of the pathology in Latvia. 




Hypoplastic left heart syndrome is a  set of con-
genital and pathogenically closely related malfor-
mations, where the central element is an atresia or 
critical stenosis of either mitral or aortic valve with 
sequential left ventricle (LV), ascending aorta and 
aortic arch hypoplasia (1).
with ensuing dilation and decreased contractili-
ty (3). At this point the LV would appear to be an 
appropriate size for gestational age on an echocar-
diogram (4, 5). The reduced flow is an inhibitor of 
further growth of the  LV, and, as the  foetus con-
tinues to increase in size, the  left heart structures 
become hypoplastic (3–6). The increasing pressure 
in the  left atrium causes the  flow through FO to 
become bidirectional or even reverse contributing 
even more to the flow decrease in the LV. Another 
factor that inhibits growth of the left heart is the en-
larged structures of the right side (6). In the case of 
MVS or MVA the hypoplasia is caused by the de-
creased preload and pressure in the LV (3, 6). Dilat-
ed cardio myopathy and endocardial fibroelastosis 
might be independent factors causing HLHS (7–9).
HLHS is a progressive pathology with features 
that vary in time. It cannot always be excluded 
based on non-existent anatomic changes on the foe-
tal echocardiography; deviations from the normal 
physiology must be taken into account, such as re-
verse flow in the transverse aorta, monophasic flow 
through the mitral valve, left-to-right flow through 
the FO, LV dysfunction (10).
Pulmonary veins usually drain to the left atrium, 
which is in communication with the  right atrium 
through atrial septal defect, most commonly persis-
tent FO. Seldom anomalous pulmonary vein drain-
age directly to the right atrium or either vena cava 
is observed (11–14). The ductus arteriosus in HLHS 
is typically variable in size, but of normal anatomi-
cal location (12). Morphologically the ductal tissue 
extends proximally and distally into the aortic wall, 
which is thought to be the cause of the frequently 
associated coarctation of the aorta (12, 15, 16).
HLHS is a  ductus arteriosus dependent cy-
anotic heart disease, where parallel pulmonary 
and systemic circulation is maintained by the sin-
gle right ventricle. The  LV in a  child with HLHS 
is a  non-functional anatomical structure (14). 
The systolic volume is ejected into the truncus pul-
monalis, where the blood flow is divided. The pul-
monary circulation, alike in normal anatomy, is 
supplied through left and right pulmonary arter-
ies. The systemic circulation, however, is perfused 
through a common arterial structure composed of 
truncus pulmonalis, ductus arteriosus and descend-
ing aorta (15). This is the reason for ductus depend-
ency of the systemic blood flow in HLHS. The hy-
poplastic ascending aorta serves as a  common 
Fig. 1. Anatomy of hypoplastic left heart syndrome. 
Ao – transverse aorta; DA – ductus arteriosus; LA – left 
atrium; LV – left ventricle; RA – right atrium; RV – right 
ventricle; TP – truncus pulmonalis; VCI – vena cava in-
ferior; VCS  –  vena cava superior; #  –  hypoplastic as-
cending aorta; * – foramen ovale
The aetiology and pathophysiology of HLHS 
is variable, but leads to the  same outcome  –  un-
derdevelopment of the structures of the left heart. 
The  leading factors that determine this peculiar 
anatomy are divided in groups of obstruction of 
outflow from the  LV (aortic valve stenosis (AVS) 
or atresia (AVA), left ventricular outflow tract ob-
struction) or obstructed flow into the LV (restric-
tive foramen ovale (FO), deviation of septum prim-
um, mitral valve stenosis (MVS) or atresia (MVA)) 
(2). Defective aortic valve is the  most common 
cause for decreased flow in the  LV and increased 
pressure in it. The most credible scenario of evolu-
tion of hypoplasia in this case would be that the in-
creased afterload contributes to LV hypertrophy 
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coronary artery, thus a pre-ductal aortic coarctation 
may compromise an adequate perfusion of the hy-
pertrophied right heart muscle (15). Since the blood 
flow to and from the left ventricle is minute or ab-
sent, the  atrial septal defect provides the  only sig-
nificant exit from the left atrium for the pulmonary 
venous blood flow (14). Because of systemic and 
pulmonary venous blood flow merging in the right 
atrium, the approximate arterial blood oxygen satu-
ration is about 80%.
The aberrant anatomy of parallel, rather than in 
series, arranged pulmonary and systemic circula-
tion is the cause of precarious distribution of cardiac 
output to pulmonary, systemic and coronary blood 
flow (12). In the foetus the pulmonary vascular re-
sistance is far greater than systemic vascular re sis-
tance. Normal systemic and coronary perfusion 
pressure is maintained as a result of most of the car-
diac output entering the descending aorta and cere-
bral and coronary circulation through the ductus ar-
teriosus (1). The said aberrant anatomy in the foetus 
does not lead to a significant impairment of the sys-
temic blood supply. The transition of circulation af-
ter birth that results in normal postnatal cardiores-
piratory physiology in a healthy child – the decline 
in pulmonary vascular resistance and the  sponta-
neous closure of ductus arteriosus – causes serious 
haemodynamic consequences in a child with HLHS. 
The spontaneous closure of ductus arteriosus com-
promises the blood flow in the systemic circulation 
including the  cerebral and coronary pool. The  de-
creased pulmonary vascular resistance reallocates 
the cardiac output in favour of pulmonary circula-
tion, and the blood flow in the lungs gradually ris-
es. In an attempt to maintain an adequate perfu-
sion in the  systemic circulation the  cardiac output 
increases, however, with the consequent increase in 
cardiac effort, the  compensatory mechanisms are 
short-lived. With rapid development of hypoxia and 
tissue ischemia metabolic acidosis ensues (1, 14, 15). 
A significant pulmonary blood flow limiting factor 
is the left atrial pressure, which is for the most part 
determined by the size of the atrial septal defect. As 
a result, a moderately restrictive flow from the left to 
right atrium with retained adequate pulmonary ve-
nous drainage might be advantageous (14).
Treatment options
There are three possible directions for therapy in 
newborns with HLHS: orthotopic heart transplan-
tation (OHT), surgical staged palliation and pallia-
tive non-surgical treatment or comfort care. Anoth-
er treatment mode – foetal therapy – has arisen and 
its options and results are being actively studied.
Staged surgical palliation was first described by 
Norwood in the 1980s. Initially the results were not 
promising, although it was the only mode of treat-
ment with the possibility of an increased lifespan. 
Shortly thereafter the  first OHTs were performed 
and the  mortality rates were lower compared to 
the  Norwood’s method. In the  thirty years since, 
results after both methods have increased dramat-
ically and a  new surgical technique has been de-
veloped  – the  hybrid procedure  –  encompassing 
the elements of palliative surgery and a transcath-
eter approach. It is not clear as to which method is 
the superior one but staged palliation is employed 
most often. Besides palliative surgery the  options 
remaining are OHT, the use of which is restricted 
by the limited number of available donors, comfort 
care or termination of pregnancy.
Foetal therapy
The purpose of foetal aortic valvuloplasty (FAV) is 
to halt the development of HLHS through altering 
the  pathologic anatomy and physiology before se-
vere arrest in growth of the left heart structures has 
occurred. FAV is a  percutaneous procedure per-
formed on about the  24th gestational week (17). 
The  procedure is performed while the  mother is 
under regional or local anaesthesia; the  foetus re-
quires anaesthesia as well and is paralysed. The foe-
tal intrauterine position is adjusted. The  mother’s 
abdominal wall, uterus, and then the foetal thoracic 
wall is punctured. The foetal LV is approached from 
the apex. The guide-wire and the balloon are intro-
duced through the stenotic aortic valve. The balloon 
is inflated repeatedly, gradually dilating the valve (3, 
18, 19).
FAV is performed on patients with aortic steno-
sis, physiologic aberrations leading to HLHS and 
a LV with a potential for functioning. As to the char-
acteristics of patients with a potentially salvageable 
LV, they remain to be specified. For now FAV is 
indicated in patients with AVS (and not AVA), bi-
directional or reverse flow in the  transverse aorta, 
retrograde flow through the  atrial septum or in-
tact septum, monophasic flow through the  mitral 
valve and decreased LV function. The establishment 
of a  biventricular (BV) circulation is considered 
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successful with enlargement of the left heart struc-
tures and increased pressure in the LV (17, 20, 21).
At the  moment the  relative success of FAV is 
reflected in two large one-centre studies as well as 
a  registry consisting of data from several smaller 
one-centre studies. The results are similar. The pro-
cedure was a  technical success in 80% of cases. 
The success rate was lower at first, but the tendency 
was to improve due to a learning curve. A BV cir-
culation was established in 43–66.7% of live-born 
neonates (17, 19, 21). Different patient groups, 
increased gestational age at the time of the proce-
dure and a  larger balloon used were the  consid-
ered factors for a better outcome in the centre with 
better results (21). Despite the  promising results 
foetal mortality – 11–18.6% – must be considered. 
The  mortality rate was higher in the  multicentre 
study where the learning curve might be slower due 
to a smaller number of cases (19).
There are no long-term results as of yet, but 
one study describes mid-term results. FAV was 
performed on 100 foetuses that were stratified in 
biventricular and univentricular outcome groups. 
There was a significant difference in neonatal mor-
tality – 12.3% in the HLHS group and 0% in the BV 
group. Although early mortality was higher in 
the HLHS group, in seven years the mortality rates 
in both groups were practically the same. The car-
diac mortality rate in patients born with BV circu-
lation (and not corrected to BV after birth) was 0%. 
The  overall 10-year survival for the  whole group 
was 72%; this is comparable to the  survival after 
staged palliation (17).
The early post-procedural complications in-
cluded foetal bradycardia, haemopericadium, LV 
thrombus, rupture of the balloon or failure to re-
tract it and intrauterine foetal death. No mater-
nal complications were reported (17, 19–21). Late 
complications were further valvular stenosis, val-
vular insufficiency, endocardial fibroelastosis, and 
myocardial fibrosis. LV remodelation with the de-
creased systolic and diastolic function has been ob-
served in patients with BV circulation (17, 19–22).
Even after achieving BV circulation cardiac in-
tervention was often necessary. In 74% of patients 
there had been at least one cardiac catheterization, 
at least one surgical intervention was required in 
84%. Overall, 97% of patients with BV circulation 
after birth needed further invasive therapy  (17). 
Balloon valvuloplasty and valvular replacement 
were the procedures most often performed amongst 
these patients (17, 19–21).
Another modality of foetal therapy is atrial septo-
plasty performed on patients with established HLHS 
and a  restrictive or an intact atrial septum. This 
procedure might prevent or alleviate pulmonary 
venous hypertension, allow for effective pulmonary 
blood flow and prevent postnatal hypoxemia (23). 
The atrial septum is approached from the right atri-
um. If needed, the septum is perforated, afterwards 
a balloon is introduced and inflated. A stent is im-
planted in the case of a thick atrial septum (3).
The number of cases with an intact septum is 
small (6–19% of all the HLHS cases), and it is not 
yet clear as to which is the  most appropriate tac-
tic and when should it be applied. In one study 
the  procedure was performed in 21 foetuses on 
a mean gestational age of 29 weeks. Procedural re-
lated death occurred in two cases. Twelve patients 
required urgent left atrial decompression after 
birth; the  condition was stable in seven patients 
with medical therapy (24). To prevent closure of 
the interatrial connection, a stent may be implant-
ed (25, 26).
Norwood procedure
Stage I palliation in HLHS is the Norwood proce-
dure. Its aims are to 1) allow for an unobstructed 
blood flow from the right ventricle to the system-
ic circulation, 2)  establish a  connection between 
the systemic and the restricted pulmonary circula-
tion, 3) provide an unobstructed flow from the pul-
monary veins through the atrial septum to the right 
atrium (19). The procedure is performed shortly af-
ter birth. It has some variations based on individual 
anatomy. The ductus arteriosus is ligated, the trun-
cus pulmonalis is separated and the distal end is su-
tured. The hypoplastic native aorta is longitudinal-
ly incised beyond the opening of ductus arteriosus. 
A neo-aorta is constructed from the native aorta, 
the proximal end of truncus pulmonalis and a pul-
monary homograft or an auto-pericardium; this is 
the  connection between the  RV and the  systemic 
circulation. Septum primum is excised establish-
ing an unobstructed junction between the  atria. 
The  pulmonary circulation is ensured through 
a modified Blalock-Taussig (BT) shunt, which con-
nects a pulmonary artery with a brachiocephalic or 
a subclavian artery, or a shunt from the right ven-
tricle to a pulmonary artery (13, 27, 28).
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Hybrid procedure
The hybrid procedure is an alternative choice to 
the first stage of the classic staged repair technique 
and is performed during the first week of a child’s 
life. It consists of a  bilateral pulmonary artery 
banding and a stent placement in ductus arteriosus 
to secure the right to left shunt (1, 29). This grants 
a  restrictive blood flow to the  lungs, while main-
taining a  systemic perfusion. The  hybrid proce-
dure is frequently performed simultaneously with 
the  trans-catheter enlargement of the atrial septal 
defect or interatrial stent placement. During the hy-
brid procedure, unlike in the Norwood operation, 
cardiopulmonary bypass and cardiac arrest, which 
are both significant insult to the child’s not yet fully 
matured myocardium, is not required. For this rea-
son, the  hybrid procedure is the  surgical method 
of choice for high risk (premature, low birthweight, 
CNS developmental defect, multiple organ failure, 
restrictive atrial septal defect, severe ventricular 
dysfunction, severe atrioventricular regurgitation) 
HLHS patients (1, 2, 12, 16, 29). The persistent risk 
of a  haemodynamically significant preductal aor-
tic coarctation with compromised coronary artery 
perfusion is a major flaw of the hybrid procedure. 
The  stage two procedure succeeding the  hybrid 
procedure is a combination between the Norwood 
and the bidirectional Glenn operation (1, 16).
Fig. 2. Norwood procedure. Neo  –  neoarta; LA  –  left 
atrium; LV  –  left ventricle; PA  –  pulmonary artery; 
RA – right atrium; RV – right ventricle; SA – subclavian 
artery; VCI – vena cava inferior; VCS – vena cava su-
perior; # – modified Blalock-Taussig shunt; * – foramen 
ovale
Fig. 3. Hybrid procedure. Ao  –  transverse aor-
ta; DA  –  stent in ductus arteriosus; LA  –  left atrium; 
LV – left ventricle; RA – right atrium; RV – right ventri-
cle; TP – truncus pulmonalis; VCI – vena cava inferior; 
VCS – vena cava superior; # – pulmonary artery band-
ing; * – balloon in foramen ovale
Bidirectional Glenn procedure
Initially the Fontan operation was performed during 
the first year of life as the second stage after a suc-
cessful Norwood operation, however, this approach 
was associated with high morbidity and mortality 
rates. Accordingly, an inter-stage was introduced – 
a  bidirectional superior cavo-pulmonary anas-
tomosis (Glenn or hemi-Fontan operation) (13). 
The  second stage is a  transition from a  high pres-
sure arterial supply to the  pulmonary blood flow 
to a  venous one, through creating an anastomosis 
between the superior vena cava and the pulmonary 
artery. The  original parallel conduit of pulmonary 
and systemic circulations is rearranged into series. 
During the Glenn operation the superior vena cava 
is separated from the right atrium and connected to 
the pulmonary artery, the superior vena cava ostium 
91HLHS: A review
and the  BT shunt is closed. Thus the  pulmonary 
circulation is perfused with the  fully desaturated, 
rather than mixed, blood from the systemic venous 
flow, while the pulmonary venous flow is conveyed 
to the  systemic circulation alone. The  pulmonary 
perfusion is achieved passively owing to the pres-
sure difference between the superior vena cava and 
pulmonary veins. In the  hemi-Fontan technique, 
the  superior vena cava is not fully detached from 
the right atrium, but its inlet is closed by a patch (1, 
2, 13). The second stage operation is performed at 
3 (4) to 6 months of age (1, 2, 12, 13).
the  right atrium. Thus the  systemic circulation is 
perfused exclusively with fully saturated blood, 
enhancing oxygen delivery. The  operation is per-
formed using either one of the  following tech-
niques: 1) by creating a lateral tunnel using a patch, 
that connects the inlets of the inferior and superior 
vena cava or 2) a modification of the original Fon-
tan technique using an extra-cardiac conduit – vas-
cular prosthesis – to connect the inferior vena cava 
to the pulmonary artery (2, 13, 30). At the moment 
there is no unanimous attitude towards the  most 
appropriate age for completion of the  full Fontan 
circulation. Generally, the Fontan operation is per-
formed at 18 to 36 months, however, in some pro-
grams the final stage is delayed until the manifesta-
tion of failing Glenn circulation – desaturation and 
cyanosis during physical activity – thus completing 
the staged repair at 3 to 5 years of age (1, 2, 13).
Fig. 4. Bidirectional Glenn procedure. Neo  –  neoarta; 
LA – left atrium; LV – left ventricle; PA – pulmonary ar-
tery; RA – right atrium; RV – right ventricle; VCI – vena 
cava inferior; VCS  –  vena cava superior; *  –  foramen 
ovale
Fig. 5. Fontan procedure. ExC – extra-cardiac conduit; 
Neo  –  neoarta; LA  –  left atrium; LV  –  left ventricle; 
PA – pulmonary artery; RA – right atrium; RV – right 
ventricle; VCI – vena cava inferior; VCS – vena cava su-
perior; * – foramen ovale
Fontan procedure
In the  third stage a  total cavo-pulmonary anas-
tomosis or full Fontan circulation is formed. 
The Fontan operation, in which the systemic arte-
rial and venous blood flow is completely separated, 
is the  final stage, and the  full Fontan circulation 
is the  end goal of the  palliative surgical therapy. 
During the  Fontan operation the  inferior vena 
cava is connected to the pulmonary artery bypass-
ing the  heart, thereby the  entire systemic venous 
flow enters the pulmonary circulation rather than 
Outcome of staged palliation
Staged palliation is the only means for survival until 
OHT. The six-year survival after the Norwood pro-
cedure is 62%. Both early and 6-year survival was 
higher if the  right ventricle to the  pulmonary ar-
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tery shunt was used compared to the modified BT 
shunt  (31). In the  leading cardiac surgery centres 
the 30-day survival is 85–90% (28, 32). The mor-
tality rate from the  30th day of life until stage II 
palliation is 12–22% (28). The mental and psycho-
motor development has been proven to be lower in 
patients after the Norwood procedure (33). Fifty to 
70% of patients who have gone through all three 
stages of palliation live to the age of 5 years (2).
Over the  past decade, an increasing attention 
has been paid to the long-term outcome of staged 
palliation of HLHS. It is a surgical therapy, with an 
intent to create the full Fontan circulation, that is 
based on a  single functioning right ventricle and 
a  common circulatory loop with pulmonary and 
systemic circulations arranged in series (14, 12, 
34). The  described haemodynamics is associat-
ed with a gradual change in the pulmonary vessel 
structure and function, and therefore increasing 
pulmonary vascular resistance, with a leading role 
in the late Fontan circulatory failure, thus making 
Fontan physiology a temporary solution, on the av-
erage lasting 4.9 years, that inevitably requires an 
OHT (35). Fontan circulation is associated with 
a considerably reduced exercise capacity and such 
potentially lethal complications as protein-losing 
enteropathy, plastic bronchitis, arrhythmias and 
progressive heart failure. Furthermore, the  said 
physiology is thought to have the  most rapid de-
cline in efficiency during the  first 6  months (36). 
In surveys adults with Fontan circulation report 
inferior exercise capacity, mental health, ability to 
integrate into society and health overall (37).
The exact cause of the  protein-losing enteropa-
thy in patients with Fontan circulation is not clear, 
however, it is thought to be associated with insuf-
ficient intestinal mucosal blood supply, chronic in-
flammation and impaired lymphatic drainage (2, 36, 
38). The  reported prevalence of the  protein-losing 
enteropathy is 3 to 24% in the  Fontan circulation 
patients (30, 36, 38, 39). The  characteristic clinical 
presentation consists of a  hypoproteinaemia syn-
drome  –  peripheral oedema, ascites and transu-
date in the  pericardial and pleural cavities (2, 36). 
The  protein-losing enteropathy following the  Fon-
tan operation is associated with increased morbidity, 
and the 5-year mortality approaches 50% (30).
Plastic bronchitis is a rare complication observed 
in children with Fontan circulation. Characteristic 
features include excessive sputum and viscous se-
cretion collection in the bronchi with consequent 
bronchial obstruction and ventilation impairment. 
The pathogenesis is not clear, however, it is believed 
to involve increased systemic and pulmonary ve-
nous pressure and hindered lymphatic drainage, 
and therefore an increased amount of protein en-
tering small airways (2, 36).
One of the  leading non-perioperative causes of 
death in Fontan circulation patients is heart rhythm 
disturbances with an incidence of 7 to 50%, further-
more, 20 years following completion of the Fontan 
circulation more than half of the  patients suffer 
supraventricular tachyarrhythmias (39). Various 
arrhythmias have been reported, including supra-
ventricular tachycardia, atrial fibrillation and sinus 
node dysfunction. Lateral tunnel is associated with 
an increased risk of cardiac arrhythmias (30 to 50%) 
compared to extra-cardiac conduit (8 to 10%) (2).
The mental development of patients has been 
evaluated to be normal with a  mean intelligence 
quotient (IQ) of 94 points (40). In a survey of parents 
of children with HLHS they report their children’s 
academic achievements to be the average (42%), and 
an equal amount reported their child’s achievements 
to be above the  average. The  most common com-
plaint was difficulty in concentrating (37). Limita-
tion of the mental function post transplantation is 
equal to that of post staged palliation with IQ < 70 
in 18% of cases (2). A  correlation has been found 
between the duration of stay in the transplant wait-
ing list and a lower IQ – a decrease of 4.5 points per 
month. The social skills of children after staged palli-
ation are not impaired (2). In a survey of adults with 
HLHS limitations in physical capacity and the over-
all health were reported, but the  level of everyday 
energy was noted to be similar to the general popu-
lation. There was no indication of a higher chronic 
pain level. Sixty-five percent of the responders were 
employed (37).
There are reports of pregnancies in patients with 
Fontan circulation. In a study of 14 pregnant wom-
en two had a cardiovascular complication (supra-
ventricular tachycardia and heart failure) although 
in both cases the outcome of labour and birth was 
successful (2).
Orthotopic heart transplantation
OHT is a corrective, rather than palliative, surgical 
technique, based on restoring normal cardiac anato-
my and near normal cardiovascular physiology (34). 
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In the  long term, transplantation is the  better 
choice to assure the best quality of life, compara-
ble to general population, and the highest survival. 
The average 5-year survival in children treated with 
OHT as a first line therapy is 65%, which is similar 
to that for staged repair, 50 to 70% (2, 34). However, 
it should be taken in account that OHT performed 
in newborns is associated with much better results 
when compared to other age groups – 16-year sur-
vival in these patients is 74% – which is probably 
due to development of selective immune tolerance 
to the  transplant. Ten years following the  OHT 
there is no exercise limitation in 93% (41). Never-
theless, a significant obstacle to OHT and the rea-
son for necessity of staged repair is the lack of heart 
donors. The transplant must fit the size of the re-
cipient’s thoracic cavity, thus only a newborn heart 
can be used, which substantially limits the number 
of donors. This makes OHT during the first 30 days 
of life rarely attainable, despite the excellent results. 
Transplantation performed after the  first 30 days 
of life has a considerably worse outcome – 10-year 
survival not reaching 50% (34). Infants and children 
on the heart transplant waiting list have the highest 
mortality rates – 17 to 25% – compared with oth-
er transplant waiting lists owing to the  long wait-
ing time (2, 42). Furthermore, the  said mortality 
has increased over the past two decades (43). One 
opinion towards OHT is that it should be reserved 
for patients with no other options of therapy than 
transplantation, for example, congenital cardiomy-
opathies (44).
Comfort care
Considering the  feeble prognosis in HLHS and 
the costs of surgical therapy, a non-surgical palli-
ative therapy is often opted for. It is a passive ap-
proach – the child is being anesthetized and sedat-
ed, but the prostaglandin therapy is withheld – with 
a  lethal outcome usually during the  first week of 
life. A satisfactory outcome of staged repair is for 
the most part reliant on the compliance of parents, 
and high perioperative and inter-stage medical care 
quality, but when lacking in this regard, the expect-
ed survival and quality of life may not be in accor-
dance with the encouraging results from the lead-
ing cardio surgery centres reported in literature. In 
addition, 15 percent of HLHS cases are associated 
with a genetic syndrome or a serious extra cardiac 
malformation (16).
Medical care of HLHS in Latvia
In the  time period of 2010–2014, twenty-six cas-
es of HLHS were diagnosed antenatally. Of these, 
17 pregnancies were terminated. In the time peri-
od of 2006–2014, twenty-four patients with HLHS 
were treated in Children’s Clinical University Hos-
pital, Riga. At the  moment 5 children are being 
observed: one after the hybrid procedure and four 
post stage  II palliation. Two hybrid procedures 
were performed in Latvia with stage II performed 
in the United Kingdom. Two patients were trans-
ferred to Germany after birth where the Norwood 
and Glenn procedures were performed. Eight chil-
dren did not reach the staged palliative repair, elev-
en died during the hybrid or Norwood procedure 
or in the early postoperative period.
CASE REPORT
A female at 40-week gestation was born to a pri-
migravida 18-year-old mother in spontaneous la-
bour. Despite having no pregnancy risk factors for 
a  cardiac anomaly, a  congenital heart disease was 
suspected on a  routine week 22 sonogram and 
the patient was referred to a paediatric cardiologist 
where an echocardiogram was performed. No flow 
through the mitral and the aortic valve was visu-
alised. The  left ventricle and the  ascending aorta 
was hypoplastic. Retrograde flow in the ascending 
aorta via ductus arteriosus and through foramen 
ovale was visualised. The  diagnosis of HLHS was 
confirmed.
The baby was born in a delivery centre special-
ising in abnormal pregnancies. The  birthweight 
was 3,060 g, the Apgar score was 8 and 9 in the first 
and fifth minute, respectively. After initiating pros-
taglandin E1 infusion 0.05 mcg/kg/min, the new-
born was transferred to the  NICU in Children’s 
Clinical University Hospital in Riga. An echocar-
diogram was performed in which a  hypoplastic 
left ventricle with no flow through the mitral and 
the aortic valve was visualised. The annulus fibro-
sus was 2–3  mm, the  pulmonary artery diameter 
was 10–12 mm, there was a patent ductus arterio-
sus 5–6 mm wide, the foramen ovale was 10 mm in 
diameter with a non-restrictive left to right shunt. 
Clinically the  newborn corresponded to NYHA 
class II–III cardiovascular failure. After physical 
and an extensive instrumental evaluation no other 
congenital malformations were found.
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A hybrid procedure was scheduled as an initia-
tion for staged repair. Preoperatively the patient was 
managed with no sedation, neither inotropic nor 
respiratory support, receiving continuous prosta-
glandin E1 infusion, as well as furosemide, spirono-
lactone and carvedilol for heart failure treatment, 
and omeprazole for stress ulcer prophylaxis. A hy-
brid procedure was performed in accordance with 
the technique described previously.
After the  procedure the  child received inotrop-
ic support with dopamine, thrombosis prophylaxis 
with heparin, followed by aspirin and clopidogrel, 
and sedation with fentanyl. On the echocardiography 
imaging there was a non-restrictive left to right shunt 
through the foramen ovale. The flow in the PDA was 
intensive and retrograde to the  aorta with arteri-
al blood saturation on pulse oxymetry (SpO2) 76 to 
85%. The right ventricle ejection fraction was 58%. 
The overall condition was stable and the patient was 
extubated on the fifth postoperative day. On the sev-
enth postoperative day the patient’s condition deterio-
rated rapidly with respiratory distress and cardiovas-
cular compromise (recapilarization time 4 sec, mean 
blood pressure 37  mmHg, metabolic acidosis with 
anion gap 40.8 mmol/l). An echocardiography im-
aging was performed; the ejection fraction was 45% 
while the SpO2 had increased to 93% (FiO2 = 0.21). 
A preductal aortic coarctation was suspected which 
was confirmed on the CT angiography. Concurrently 
stenting of the coarctation was performed.
Fig. 6. Echocardiography image. Api-
cal four-chamber view. The left atri-
um  (LA) is much smaller than the 
right atrium (RA). Rudimentary left 
ventricle (LV), aortic and mitral valve 
atresia. The right ventricle (RV) occu-
pies the cardiac apex
Fig. 7. Echocardiography image. Su-
prasternal long-axis view. Preductal 
coarctation of the aorta (Co Ao). Retro-
grade flow from stented ductus to trans-
verse arch (Ao arch)
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There was an immediate improvement (ejec-
tion fraction 63%). The  patient was extubated on 
the  second postoperative day and required no 
supplemental oxygen therapy from the  fourth 
postoperative day. As the condition remained rel-
atively stable during the  first postoperative week, 
the  patient was transferred to the  Neonatal Care 
Unit. Despite continuous adjustment of therapy 
for heart failure, the  overall condition slowly de-
teriorated with decreasing the  ejection fraction 
and progressive systemic and pulmonary conges-
tion. On the 54th day of life the overall condition 
worsened rapidly and the  patient was transferred 
back to the NICU where inotropic and ventilatory 
support was initiated. The  therapy was ineffective 
and shortly thereafter cardiac arrest occurred. Car-
diopulmonary resuscitation was unsuccessful and 
the patient died.
CONCLUSIONS
The advancements in surgical management and im-
provements in intensive care of patients with HLHS 
allow for a better outcome for this pathology com-
pared to the  recent past. Still, the  superior mode 
of treatment is not yet clear and the management 
must be based on each individual case, the experi-
ence of each clinic, as well as the financial aspects 
and will of the patient’s parents.
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KAIRIOSIOS ŠIRDIES HIPOPLAZIJOS 
SINDROMAS: APŽVALGA
Santrauka
Prielaida. Kairiosios širdies hipoplazijos sindromas 
(KŠHS) etiologiniu požiūriu yra daugiaveiksnė įgimta 
širdies liga, kuria suserga vienas iš 5000 naujagimių. Prieš 
trisdešimt metų gydyti šią patologiją galimybių nebuvo ir 
paprastai pirmosiomis gyvenimo savaitėmis ligos eiga na-
tūraliai baigdavosi mirtimi. Neseniai atsiradę paliatyvio-
sios chirurgijos intervencijos metodai ligos atveju leidžia 
išgyventi penkerius metus daugiau nei pusei pacientų.
Medžiagos ir metodai. Peržvelgėme literatūrą apie 
KŠHS, jos anatomiją, embriologiją, patofiziologiją ir gy-
dymą. Atliktos paieškos PubMed ir ClinicalKey duome-
nų bazėse naudojant raktinius žodžius kairiosios širdies 
hipoplazijos sindromas, vaisiaus aortos valvuloplastika, 
vaisiaus septoplastika, Norwood procedūra, dvikryptė 
Gleno procedūra, Fontan procedūra, hibridinė procedū-
ra. Analizuota atitinkama literatūra, aptikta informacija 
panaudota straipsnyje. Kaip taikomo gydymo pavyzdį 
Latvijoje aprašėme ligos atvejį Rygos vaikų klinikinėje 
universitetinėje ligoninėje.
Rezultatai. Galimos trys sergančių KŠHS naujagi-
mių gydymo terapijos kryptys: ortotopinė širdies trans-
plantacija, sudėliotas chirurginis lengvinantis gydymas 
ir paliatyvioji ne chirurginė terapija arba komforto prie-
žiūra. Pradėtas taikyti naujas gydymo būdas – vaisiaus 
terapija. Lengvinantis gydymas ir pilna Fontan cirku-
liacija yra laikinas sprendimas, tačiau tai vienintelė iš-
gyvenimo priemonė iki širdies transplantacijos. Nuo 50 
iki 70 % pacientų, kurie ištvėrė visus tris lengvinančio 
gydymo etapus, gyveno iki penkerių metų.
Išvados. Aukščiausio režimo gydymas dar nėra aiš-
kus ir ligos valdymas turi būti pagrįstas kiekvienu kon-
krečiu atveju, klinikos patirtimi, taip pat finansiniais 
aspektais ir paciento tėvų valia.
Raktažodžiai: kairiosios širdies hipoplazijos sindro-
mas, Norwood procedūra, dvikryptė Gleno procedūra, 
Fontan procedūra, hibridinė procedūra, balioninė val-
vuloplastika
